DuraSeal [clinicaltrials_resource:NCT00704340/group/E1]
DuraSeal Dural Sealant System - FDA Approved Device
Total, serious adverse events for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/1/count/1]Pancreatitis for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/10/count/19]C. Difficile for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/11/count/21]Deep Incisional SSI for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/12/count/23]Superficial Incisional SSI for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/13/count/25]Aseptic meningitis for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/14/count/27]Late incisional SSI for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/15/count/29]Malignant Metastatic melanoma for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/16/count/31]Acute Gait Dysfunction/Readmission for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/17/count/33]evacuation of epidural hematoma for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/18/count/35]Seizure for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/19/count/37]Blood clot for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/2/count/3]Headache and intractable nausea/vomiting for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/20/count/39]Headache for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/21/count/41]Cerebral hemmorhage for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/22/count/43]CSF leak for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/23/count/45]headache/double-vision for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/24/count/47]left hemiplegia for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/25/count/49]hydrocephalus for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/26/count/51]cerebral vasospasm for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/27/count/53]cerebral edema for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/28/count/55]brain tumor for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/29/count/57]Central diabetes insipidus for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/3/count/5]severe neurological deficit post-op for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/30/count/59]Pneumonia for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/31/count/61]Deep Vein Thrombosis for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/4/count/7]Bacteremia for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/5/count/9]pulmonary embolus for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/6/count/11]Transient Ischemic Attack (T.I.A.) for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/7/count/13]Cerebrovascular Accident (C.V.A.)- also known as stroke for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/8/count/15]nausea/vomiting for NCT00704340 for E1 in NCT00704340 [clinicaltrials_resource:NCT00704340/serious_events/9/count/17]Reported events for NCT00704340 [clinicaltrials_resource:d8e1ad3f7b4a086f2ed3b69f4f31fbb0]
group [clinicaltrials_vocabulary:group]
DuraSeal [clinicaltrials_resource:NCT00704340/group/E1]
DuraSeal Dural Sealant System - FDA Approved Device
Bio2RDF identifier
NCT00704340/group/E1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00704340/group/E1
group id [clinicaltrials_vocabulary:group-id]
description
DuraSeal Dural Sealant System - FDA Approved Device
@en
identifier
clinicaltrials_resource:NCT00704340/group/E1
title
DuraSeal
@en
type
label
DuraSeal [clinicaltrials_resource:NCT00704340/group/E1]
@en